Meredith Adler

Barclays commented on Family Dollar Stores, Inc. (NYSE: FDO) after the company missed Q1 expectations and noted that the merger delay is “harmful.” Analyst Meredith Adler commented that while results were soft and Q2 may not be much better there were some positive points from...

Meredith Adler of Barclays maintained an Equal-Weight rating on Walgreen Company (NYSE: WAG) with a price target raised to $72 from a previous $68 following the company's first quarter results. According to Adler, Walgreen's results were “ahead of expectations” and during the earnings call, the...

Shares of CVS Health Corp (NYSE: CVS) were the best performing name in the Drug Retailer group Monday, declining about 0.95 percent to close at $80.60. Shares of Walgreen (NYSE: WAG) and Rite Aid (NYSE: RAD), meanwhile, fell about 3.9 percent and 4.5 percent, respectively. Traders on the Street...

Dollar Tree's (NASDAQ: DLTR) relatively robust same-store sales growth of late resulted from a tactic that could get a big boost from its controversial plan to acquire Family Dollar Stores (NYSE: FDO). Same-store sales grew 4.5 percent in the recent quarter, the fastest rate since 2011 and...

Wal-Mart Stores (NYSE: WMT) shares were sinking Friday on a disappointing third-quarter outlook, but analysts weren't ready to throw in the towel. The company's soft second quarter shows "the benefits are still to come" from its plan to improve U.S. stores and stabilize...

CVS Caremark's (NYSE: CVS) second-quarter performance in its prescription benefits management segment drew plaudits from analysts Wednesday. CVS is among the five largest such managers in the U.S., and the only one with an attached retail operation. Most insured Americans receive drug benefits...

Kroger (NYSE: KR) hit a 52-week high last Friday in intra-day trading, but analysts were divided at the current valuation. Kroger on Thursday posted adjusted quarterly earnings of $1.09 per share, up more than 18 percent from a year earlier and $0.04 ahead of estimates. Sales grew 10 percent to...

Barclays released a research note Tuesday in which the firm downgraded Weight Watchers (NYSE: WTW) from Equal-Weight to Underweight and lowered the price target from $31 to $15, perhaps marking the first time the company is unhappy about weight loss. Barclays' Meredith Adler summarized the firms...

Analyst Meredith Adler of Barclays Capital maintains his “overweight” rating on Kroger Co (NYSE: KR), while reducing his estimates for the company. The target price for KR has been reduced from $28 to $26. KR has reported its Q3 EPS significantly short of expectations due to stiff competition in...